An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People with Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States First published 23/09/2024 Last updated 20/10/2026 EU PAS number:EUPAS1000000231 Study Finalised
RTI Health Solutions (RTI-HS) France Spain Sweden United Kingdom United Kingdom (Northern Ireland) United States First published:21/04/2010 Last updated 11/08/2026 Institution Not-for-profit ENCePP partner
Bayer Clinical Trials Contact clinical-trials-contact@bayer.comStudy contactclinical-trials-contact@bayer.com